MIAMI — Talent Testing Service issued a statement today regarding recent adult industry concerns regarding performer testing.
TTS, which now plans on enhancing its Gold Standard Panel test, said the following:
As a primary stakeholder in the protection of the health of adult performers in the industry, Talent Testing Service has been at the forefront in providing best-in-class testing services since 2005. We have been able to provide these services primarily due to the fact of being highly involved in the developmental process of the ever evolving science of infectious disease testing with our diagnostic and molecular testing partners.
At this moment our data disputes the recent statements circulating, in the adult industry, regarding “undetectable=untransmittable” since this cannot be proven at a 100 percent accuracy. We would rephrase this as “undetectable = extremely low probability of transmission.”
Due to this extremely low probability of transmission, however minute, it is still a risk and we should all err on the side of caution.
Our quality assurance (QA) program mandates that we randomly verify through different peer programs the accuracy and specificity of the assays to make sure they are working as expected.
In addition to this, our QA program also takes into consideration external factors that may affect the veracity and integrity of the testing program we have in place. As a whole, the QA program is an ever evolving process striving to achieve one goal — the safety of adult performers.
After listening to the industry’s concerns, “Talent Testing Service will not only continue to participate in the peer program described above, but the Gold Standard Panel (GSP) will be enhanced to include the Genetic Systems HIV-1/HIV-2 Plus O EIA. This is an FDA cleared test to detect antibodies against HIV-1, HIV-2 and Group O. This test is being added to the GSP at no additional cost,” said Sixto Pacheco, president and CEO of Talent Testing Service.
“These changes come after consultations with talents, agents and production companies throughout the industry,” Pacheco said. “TTS prides itself on being at the forefront of industry leading testing protocols.
“The new GSP test is in line with our commitment to continuously improve the available safeguards directed at the health of the talent and the industry as a whole.”
At this moment we recommend that the Free Speech Coalition direct their licensed healthcare providers to implement the same immediately.